相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The tumour immune landscape and its implications in cutaneous melanoma
Grace H. Attrill et al.
PIGMENT CELL & MELANOMA RESEARCH (2021)
Resistance mechanisms to targeted therapy in BRAF-mutant melanoma - A mini review
Lokeswari P. Tangella et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2021)
Safety of BRAF plus MEK Inhibitor Combinations: Severe Adverse Event Evaluation
Tomer Meirson et al.
CANCERS (2020)
Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patients
Lauren G. Aoude et al.
SCIENTIFIC REPORTS (2020)
Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinoma
Evangelia Katsoulakis et al.
ORAL ONCOLOGY (2020)
The Immune Landscape of Cancer (vol 48, pg 812, 2018)
Vesteinn Thorsson et al.
IMMUNITY (2019)
The density and spatial tissue distribution of CD8+ and CD163+ immune cells predict response and outcome in melanoma patients receiving MAPK inhibitors
Daniela Massi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jerome Galon et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
A Review of Immune-Mediated Adverse Events in Melanoma
Lucy Boyce Kennedy et al.
ONCOLOGY AND THERAPY (2019)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study
Roger Sun et al.
LANCET ONCOLOGY (2018)
Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma
Tuba N. Gide et al.
CLINICAL CANCER RESEARCH (2018)
Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017
Selma Ugurel et al.
EUROPEAN JOURNAL OF CANCER (2017)
Whole-genome landscapes of major melanoma subtypes
Nicholas K. Hayward et al.
NATURE (2017)
Multifunctional Imaging Signature for V-KI-RAS2 Kirsten Rat Sarcoma Viral Oncogene Homo log (KRAS) Mutations in Colorectal Cancer
Kenneth A. Miles et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
CT texture analysis using the filtration-histogram method: what do the measurements mean?
Kenneth A. Miles et al.
CANCER IMAGING (2013)
RNA-SeQC: RNA-seq metrics for quality control and process optimization
David S. DeLuca et al.
BIOINFORMATICS (2012)
qpure: A Tool to Estimate Tumor Cellularity from Genome-Wide Single-Nucleotide Polymorphism Profiles
Sarah Song et al.
PLOS ONE (2012)
F-18-fluoro-2-deoxyglucose positron emission tomography (PET) and PET/computed tomography imaging in primary staging of patients with malignant melanoma: a systematic review
Milly A. Schroeer-Guenther et al.
SYSTEMATIC REVIEWS (2012)
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Bo Li et al.
BMC BIOINFORMATICS (2011)